This mechanism highlights the intricate link between cancer‐related inflammation, hepcidin regulation, and anemia, underscoring the impact of systemic inflammation on iron metabolism in breast cancer patients [62, 70]. This evidence concerns the gene HAMP and anemia (phenotype).